Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

The role of the immune system in the control of hepatocellular carcinoma

Immunotherapeutic strategies for hepatocellular carcinoma

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis

Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit